Antihypertensive agents and prevention of dementia

BMJ (Online)

Volumn 340, Issue 7738, 2010, Pages 111-112

  Maxwell, Colleen J ^a   Hogan, David B ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LISINOPRIL;

ALZHEIMER DISEASE; ANTIHYPERTENSIVE THERAPY; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEMENTIA; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG RECEPTOR BINDING; EDITORIAL; FOLLOW UP; HUMAN; HYPERTENSION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BLOCKING; RISK REDUCTION; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT OUTCOME;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANTIHYPERTENSIVE AGENTS; DEMENTIA; HUMANS;

EID: 74949127613     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.b5409     Document Type: Editorial

References (12)

1. Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, et al., for Alzheimer's Disease International. Global prevalence of dementia: a Delphi consensus study. Lancet 2005;366:2112-7. [CrossRef][Web of Science][Medline]
2. Stewart R, Xue Q-L, Masaki K, Petrovitch H, Webster Ross G, White LR, et al. Change in blood pressure and incident dementia: A 32-year prospective study. Hypertension 2009;54:233-40. [Abstract/Free Full Text]
3. Qiu C, Winblad B, Fratiglioni L. The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 2005;4:487-99.[CrossRef][Web of Science][Medline]
4. Li NC, Lee A, Whitmer RA, Kivipelto M, Lawler E, Kazis LE, et al. Use of angiotensin receptor blockers and the risk of dementia in a predominantly male population: prospective cohort analysis. BMJ 2010;340:b5465.[Abstract/ Free Full Text]
5. Haag MD, Hofman A, Koudstaal PJ, Breteler MM, Stricker BH. Duration of antihypertensive drug use and risk of dementia: a prospective cohort study. Neurology 2009;72:1727-34.[Abstract/Free Full Text]
6. Duron E, Rigaud AS, Dubail D, Mehrabian S, Latour F, Seux ML, et al. Effects of antihypertensive therapy on cognitive decline in Alzheimer's disease. Am J Hypertens 2009;22:1020-4.[CrossRef][Web of Science][Medline]
7. Takeda S, Sato N, Takeuchi D, Kurinami H, Shinohara M, Niisato K, et al. Angiotensin receptor blocker prevented β-amyloid-induced cognitive impairment associated with recovery of neurovascular coupling. Hypertension 2009;54:1345-52.[Abstract/Free Full Text]
8. Forette F, Seux ML, Staessen JA, Thijs L, Birkenhager WH, Babarskiene MR, et al; on behalf of the Syst-Eur Investigators. Prevention of dementia in randomized double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998;352:1347-51.[CrossRef][Web of Science][Medline]
9. McGuinness B, Todd S, Passmore P, Bullock R. Blood pressure lowering in patients without prior cerebrovascular disease for prevention of cognitive impairment and dementia. Cochrane Database Syst Rev 2009;(4):CD004034.
10. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci 2005;229-230:151-5.
11. Nagai M, Hoshide S, Kario K. Hypertension and dementia. Am J Hypertens 2009 Online November 19.
12. Poon I, Lai LS, Ford ME, Braun UK. Racial/ethnic disparities in medication use among veterans with hypertension and dementia: a national cohort study. Ann Pharmacother 2009;43:185-93. [Abstract/Free Full Text]